(Other OTC:LIMX),(OTC US:LIMX), Los Angeles, CA, July 07, 2025 (GLOBE NEWSWIRE) — Limitless X Holdings, Inc. (OTCQB: LIMX), a leading innovator in health, wellness, and performance-driven lifestyle solutions, proudly announces the official launch of Limitless Nootropic Blend Coffee Concentrate, a breakthrough instant coffee product developed by its wholly owned subsidiary, Limitless X, Inc. This product […]

Baltimore, MD, July 07, 2025 (GLOBE NEWSWIRE) — A released presentation by economic strategist Jim Rickards is drawing fresh attention just as President Trump prepares to introduce his most sweeping economic legislation to date–a bill insiders are calling “The Big Beautiful Bill.” Rather than focus on how much Trump's overhauls might cost, Rickards is asking

(NYSE MKT: VTAK), FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it has received a purchase order from Centre Hospitalier Universitaire (CHU) de Rennes. This is the first

(NASDAQ:LENZ), SAN DIEGO and CLERMONT-FERRAND, France, July 07, 2025 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Laboratoires Thea (“Thea”) announced an exclusive license and commercialization agreement for Thea to register and commercialize LNZ100 for the treatment of presbyopia in Canada. LENZ Therapeutics is a pre-commercial stage biopharmaceutical company focused on the development and

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) — For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals the progression of cognitive impairment and Alzheimer's disease. The assessment (here) can be self-administered and completed in about three minutes on internet-connected

(TSE:4519.T), Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through Gero's AI-driven human data-first platform Accelerating the creation of innovation by combining Gero's aging-focused target discovery technology with Chugai's drug discovery technologies TOKYO, July 07, 2025 (GLOBE NEWSWIRE) — Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519, hereafter

(NASDAQ:ABSI), VANCOUVER, Wash., July 07, 2025 (GLOBE NEWSWIRE) — Absci (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the appointment of veteran biopharmaceutical executive Mary Szela to its Board of Directors. With decades of R&D and commercial leadership experience, Ms. Szela has played pivotal roles in advancing transformative

(NYSE:RH), ATLANTA, Ga., July 07, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether RH (“RH” or the “Company”) (NYSE: RH) complied with federal securities laws. On January 24, 2025, Hunterbrook Media published a report alleging, among other things, that the Company's “demand metric” is misleading. The report alleges that “the growth in

(NYSE:CRS), PHILADELPHIA, July 07, 2025 (GLOBE NEWSWIRE) — Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, July 31, 2025 at 10:00 a.m. ET to discuss the results of operations for the fourth quarter of fiscal year 2025, ended June 30, 2025. The call and webcast will follow the

Toronto, Canada, July 07, 2025 (GLOBE NEWSWIRE) — Medela, the brand trusted by millions of moms worldwide and the #1 brand in hospitals1, today announced the Canadian launch of Magic InBra(TM), the most advanced wearable breast pump the brand has developed so far. Weighing just 200 grams (7 ounces), Magic InBra(TM) features an ultra-slim, anatomically